194 related articles for article (PubMed ID: 36147219)
1. Isolation and Characterization of Lytic Bacteriophages Targeting Diverse
Finney AG; Perry JM; Evans DR; Westbrook KJ; McElheny CL; Iovleva A; Doi Y; Shields RK; Van Tyne D
Phage (New Rochelle); 2022 Mar; 3(1):50-58. PubMed ID: 36147219
[No Abstract] [Full Text] [Related]
2. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
[TBL] [Abstract][Full Text] [Related]
3. Characterization and Genome Study of Novel Lytic Bacteriophages against Prevailing Saprophytic Bacterial Microflora of Minimally Processed Plant-Based Food Products.
Wójcicki M; Średnicka P; Błażejak S; Gientka I; Kowalczyk M; Emanowicz P; Świder O; Sokołowska B; Juszczuk-Kubiak E
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830335
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting
Manohar P; Tamhankar AJ; Lundborg CS; Nachimuthu R
Front Microbiol; 2019; 10():574. PubMed ID: 30949158
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of lytic bacteriophages from sewage at an egyptian tertiary care hospital against methicillin-resistant
Samir S; El-Far A; Okasha H; Mahdy R; Samir F; Nasr S
Saudi J Biol Sci; 2022 May; 29(5):3097-3106. PubMed ID: 35360502
[TBL] [Abstract][Full Text] [Related]
6. Harnessing the Diversity of
Nordstrom HR; Griffith MP; Rangachar Srinivasa V; Wallace NR; Li A; Cooper VS; Shields RK; Van Tyne D
Cells; 2024 Feb; 13(5):. PubMed ID: 38474392
[No Abstract] [Full Text] [Related]
7. Two Newly Isolated
Cieślik M; Harhala M; Orwat F; Dąbrowska K; Górski A; Jończyk-Matysiak E
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891499
[TBL] [Abstract][Full Text] [Related]
8. The Antibacterial Effects of Cocktail and Single Forms of Lytic Phages Belonging to
Jokar J; Rahimian N; Ghasemian A; Najafipour S
Biomed Res Int; 2022; 2022():7833565. PubMed ID: 36467878
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
Manohar P; Nachimuthu R; Lopes BS
BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
[TBL] [Abstract][Full Text] [Related]
10. Campylobacter spp. and bacteriophages from broiler chickens: Characterization of antibiotic susceptibility profiles and lytic bacteriophages.
Nowaczek A; Urban-Chmiel R; Dec M; Puchalski A; Stępień-Pyśniak D; Marek A; Pyzik E
Microbiologyopen; 2019 Jul; 8(7):e00784. PubMed ID: 30656847
[TBL] [Abstract][Full Text] [Related]
11. Isolation and Characterization of Lytic Bacteriophages from Wastewater with Phage Therapy Potentials Against Gram-Negative Bacteria.
Khorshidtalab M; Durukan İ; Tufekci EF; Nas SS; Abdurrahman MA; Kiliç AO
Eurasian J Med; 2022 Jun; 54(2):157-164. PubMed ID: 35703524
[TBL] [Abstract][Full Text] [Related]
12. Genomic characterization of key bacteriophages to formulate the potential biocontrol agent to combat enteric pathogenic bacteria.
Parmar KM; Dafale NA; Tikariha H; Purohit HJ
Arch Microbiol; 2018 May; 200(4):611-622. PubMed ID: 29330592
[TBL] [Abstract][Full Text] [Related]
13. Isolation and Characterization of Novel Phages Targeting Pathogenic
Li N; Zeng Y; Bao R; Zhu T; Tan D; Hu B
Front Cell Infect Microbiol; 2021; 11():792305. PubMed ID: 34926329
[No Abstract] [Full Text] [Related]
14. vB-Ea-5: a lytic bacteriophage against multi-drug-resistant
Habibinava F; Zolfaghari MR; Zargar M; Shahrbabak SS; Soleimani M
Iran J Microbiol; 2021 Apr; 13(2):225-234. PubMed ID: 34540158
[TBL] [Abstract][Full Text] [Related]
15. Harnessing the diversity of
Nordstrom HR; Griffith MP; Srinivasa VR; Wallace NR; Li A; Cooper VS; Shields RK; Van Tyne D
bioRxiv; 2024 Jan; ():. PubMed ID: 38328162
[No Abstract] [Full Text] [Related]
16. Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae.
Kęsik-Szeloch A; Drulis-Kawa Z; Weber-Dąbrowska B; Kassner J; Majkowska-Skrobek G; Augustyniak D; Lusiak-Szelachowska M; Zaczek M; Górski A; Kropinski AM
Virol J; 2013 Mar; 10():100. PubMed ID: 23537199
[TBL] [Abstract][Full Text] [Related]
17. Genomic characterization of lytic bacteriophages targeting genetically diverse
Nordstrom HR; Evans DR; Finney AG; Westbrook KJ; Zamora PF; Hofstaedter CE; Yassin MH; Pradhan A; Iovleva A; Ernst RK; Bomberger JM; Shields RK; Doi Y; Van Tyne D
iScience; 2022 Jun; 25(6):104372. PubMed ID: 35620437
[No Abstract] [Full Text] [Related]
18. Colistin Susceptibility in Companion Animal-Derived
Sato T; Harada K; Usui M; Yokota SI; Horiuchi M
Front Cell Infect Microbiol; 2022; 12():946841. PubMed ID: 35873176
[TBL] [Abstract][Full Text] [Related]
19. Preliminary survey of local bacteriophages with lytic activity against multi-drug resistant bacteria.
Latz S; Wahida A; Arif A; Häfner H; Hoß M; Ritter K; Horz HP
J Basic Microbiol; 2016 Oct; 56(10):1117-1123. PubMed ID: 27194637
[TBL] [Abstract][Full Text] [Related]
20. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation.
Zurabov F; Zhilenkov E
Virol J; 2021 Jan; 18(1):9. PubMed ID: 33407669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
